Caffeine intake, smoking, and risk of Parkinson disease in men and women.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Epidemiology

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kwr451PMID 22505763PMCID PMC3370885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update in hormone therapy use in menopause.

  2011cited by this paper
• Caffeine Exposure and the Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis of Observational Studiess

  2010cited by this paper
• Smoking duration, intensity, and risk of Parkinson disease

  2010cited by this paper
• Neuroprotective actions of sex steroids in Parkinson's disease.

  2009cited by this paper
• Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease

  2009cited by this paper
• Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk

  2008cited by this paper
• Prospective study of coffee consumption and risk of Parkinson's disease

  2008cited by this paper
• Coffee and tea consumption and the risk of Parkinson's disease

  2007cited by this paper
• OESTROGEN AND NIGROSTRIATAL DOPAMINERGIC NEURODEGENERATION: ANIMAL MODELS AND CLINICAL REPORTS OF PARKINSON'S DISEASE

  2007cited by this paper
• Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study.

  2007cited by this paper
• Pooled analysis of tobacco use and risk of Parkinson disease.

  2007cited by this paper
• Drug interactions and smoking: raising awareness for acute and critical care providers.

  2006cited by this paper
• Estrogen Prevents Neuroprotection by Caffeine in the Mouse 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease

  2006cited by this paper
• Coffee Consumption and Coronary Heart Disease in Men and Women: A Prospective Cohort Study

  2006cited by this paper
• Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease

  2005cited by this paper
• Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease

  2005cited by this paper
• Risk and protective factors for Parkinson's disease: A study in Swedish twins

  2005cited by this paper
• Coffee consumption, gender, and Parkinson's disease mortality in the cancer prevention study II cohort: the modifying effects of estrogen.

  2004cited by this paper
• A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers.

  2003cited by this paper
• Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease

  2003cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease

  2002cited by this paper
• Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

  2002cited by this paper
• Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study.

  2001cited by this paper
• Prospective study of caffeine consumption and risk of Parkinson's disease in men and women

  2001cited by this paper
• Risk Factors for Parkinson’s Disease: The Leisure World Cohort Study

  2001cited by this paper
• Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study.

  2001cited by this paper
• Association of coffee and caffeine intake with the risk of Parkinson disease.

  2000cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• American Journal of Epidemiology Original Contribution Coffee Intake, Smoking, and Pulmonary Function in the Atherosclerosis Risk in Communities Study

  year unknowncited by this paper

• Gut microbiota reconstitution and control of α-synucleinopathy with β-glucans: a promising approach for individuals with parkinson’s disease

  2025cites this paper
• Neurocognitive and Neurological Effects of Coffee and Caffeine: A Narrative Review

  2025cites this paper
• Hope vs Hype II: We should stop embarking on epidemiology-based disease modifying clinical trials (PSG debate 2024).

  2025cites this paper
• The epidemiological risk and prevention and interventions in Parkinson's disease: from a nutrition-based perspective.

  2025cites this paper
• Voiding Dysfunction and Parkinson Disease in Geriatric Patients.

  2025cites this paper
• Bidirectional relationship between olfaction and Parkinson’s disease

  2024cites this paper
• Serum 25-hydroxyvitamin D concentrations and their impact on all-cause mortality in Parkinson’s disease: insights from National Health and Nutrition Examination Survey 1999–2020 data

  2024cites this paper
• Association of caffeine intake with all-cause and cardiovascular mortality in diabetes and prediabetes

  2024cites this paper
• Epigenetic associations of GPNMB rs199347 variant with alcohol consumption in Parkinson’s disease

  2024cites this paper
• Smoking exposure and Parkinson's disease: A UK Brain Bank pathology-validated case-control study.

  2024cites this paper
• Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort

  2024cites this paper
• Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease

  2024cites this paper
• Emerging phosphodiesterase inhibitors for treatment of neurodegenerative diseases

  2024cites this paper
• Evaluating the Neuroprotective Potential of Caffeinated Coffee in the Context of Aluminum-Induced Neurotoxicity: Insights from a PC12 Cell Culture Model

  2024cites this paper
• Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems

  2024cites this paper
• Smoking, coffee intake, and Parkinson's disease: potential protective mechanisms and components.

  2024cites this paper
• Cannabidiol at Nanomolar Concentrations Negatively Affects Signaling through the Adenosine A2A Receptor

  2023cites this paper
• Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism

  2023cites this paper
• Association Between Menopausal Hormone Therapy and Risk for Parkinson’s Disease

  2023cites this paper
• Applications of Machine Learning to Diagnosis of Parkinson’s Disease

  2023cites this paper
• Bidirectional relationship between olfaction and Parkinson’s disease

  2023cites this paper
• Koffein und Schokolade als neue Therapieoptionen bei Parkinson?

  2023cites this paper
• Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework

  2023cites this paper
• Can chronic therapeutic drug use by the elderly affect Alzheimer’s disease risk and rate of progression?

  2023cites this paper
• Disease-modifying vs symptomatic treatments: Splitting over lumping.

  2023cites this paper
• Does Drinking Coffee Reduce the Incidence of Parkinson's Disease?

  2023cites this paper
• Design of encapsulation method for chlorogenic acid and caffeine in coffee waste by-product.

  2023cites this paper
• Les progrès dans la génétique de la maladie de Parkinson : quelles leçons en tirer pour la pratique clinique ?

  2022cites this paper
• A cross-sectional study of Parkinson’s disease and the prodromal phase in community-dwelling older adults in eastern Japan

  2022cites this paper
• The Potential Role of Voltage-Dependent Anion Channel in the Treatment of Parkinson's Disease

  2022cites this paper
• Improve ment of Antioxidant Activity and Sensory Quality of Pagilaran’s Tea Clones Treated by Tannase

  2022cites this paper
• Parkinson's Disease: Risk Factor Modification and Prevention

  2022cites this paper
• Effect of Paeoniae Radix Rubra (Paeonia lactiflora Pall.) extract on mucin secretion, gene expression in human airway epithelial cells.

  2022cites this paper
• Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson's disease.Prevention of neuroinflammation in Parkinson's disease.

  2022cites this paper
• The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases

  2022cites this paper
• Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder

  2022cites this paper
• Conference on Nutrition, health and ageing – translating science into practice Symposium two: Anthropometric, lifestyle and dietary concerns in ageing – diagnostic and interventional considerations Parkinson ’ s disease: the nutrition perspective

  2022cites this paper
• Relationship between Nutrition, Lifestyle, and Neurodegenerative Disease: Lessons from ADH1B, CYP1A2 and MTHFR

  2022cites this paper
• Mitochondria–lysosome crosstalk in GBA1-associated Parkinson’s disease

  2022cites this paper
• Effect of Coffee on Lipopolysaccharide-Induced Immortalized Human Oral Keratinocytes

  2022cites this paper
• Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's Disease

  2021cites this paper
• The Transcriptional Repressor Orphan Nuclear Receptor TLX Is Responsive to Caffeine and Istradefylline

  2021influential citation
• Caffeine as a Factor Influencing the Functioning of the Human Body—Friend or Foe?

  2021cites this paper
• Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells

  2021cites this paper
• Inhibitory Effect of Fermented Mentha piperita on MUC5AC in Lung Epithelial Cells

  2021cites this paper
• Parkinson's disease: Is there a role for dietary and herbal supplements?

  2021cites this paper
• Genes Implicated in Familial Parkinson’s Disease Provide a Dual Picture of Nigral Dopaminergic Neurodegeneration with Mitochondria Taking Center Stage

  2021cites this paper
• Koffein, Schokolade und Adenosin A2A Rezeptorantagonisten in der Behandlung des Parkinson Syndroms

  2021cites this paper
• Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies

  2021cites this paper
• Iron status, immune system, and expression of brain divalent metal transporter 1 and dopamine receptors D1 interrelationship in Parkinson’s disease and the role of grape seed and green coffee bean extracts and quercetin in mitigating the disease in rats

  2021cites this paper
• Does Caffeine Consumption Affect the Symptoms of Parkinson’s Disease? A Systematic Review of Clinical Trials

  2021cites this paper
• Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists

  2021cites this paper
• Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration

  2020cites this paper
• Parkinson’s Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East

  2020cites this paper
• What and How Can Physical Activity Prevention Function on Parkinson's Disease?

  2020cites this paper
• Genetics of Parkinson's disease: An introspection of its journey towards precision medicine.

  2020cites this paper
• Understanding the Links Between Cardiovascular Disease and Parkinson's Disease

  2020cites this paper
• A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities

  2020cites this paper
• Parkinson’s Disease

  2020cites this paper
• Neuroprotective Effects of Coffee Bioactive Compounds: A Review

  2020cites this paper
• Parkinson’s Disease : An Update on Pathophysiology, Epidemiology, Diagnosis and Management. Part 2 : Etiology and Pathophysiology

  2020cites this paper
• Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson’s disease?

  2020cites this paper
• Xanthine derivatives as agents affecting non-dopaminergic neuroprotection in Parkinson`s disease.

  2020cites this paper
• Istradefylline to Treat Patients with Parkinson’s Disease Experiencing “Off” Episodes: A Comprehensive Review

  2020cites this paper
• Multiple System Atrophy (MSA) and smoking: a meta-analysis and mechanistic insights

  2020cites this paper
• Risk factors for possible REM sleep behavior disorders

  2020cites this paper
• Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease

  2020cites this paper
• Understanding the pathogenesis involved in Parkinson's disease and potential therapeutic treatment strategies.

  2020cites this paper
• The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis

  2020cites this paper
• Shared Metabolic Profile of Caffeine in Parkinsonian Disorders

  2020cites this paper
• Neuroprotective and MAOB inhibitory effects of a series of caffeine-8-thioglycolic acid amides

  2020cites this paper
• Clinical Evaluation of Sibling Pairs With Gaucher Disease Discordant for Parkinsonism

  2019influential citation
• Cognitive decline, Alzheimer’s and Parkinson’s diseases : does dietary pattern play a role?

  2019cites this paper
• Association between ambient air pollution and Parkinson's disease: Systematic review and meta‐analysis

  2019cites this paper
• Pathology, Prevention and Therapeutics of Neurodegenerative Disease

  2019cites this paper
• Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?

  2019influential citation
• Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models

  2019cites this paper
• Is Parkinson’s Disease a Very Rare Pathology in Centenarians? A Clinical Study in a Cohort of Subjects

  2019cites this paper
• Pro-oxidant and lifespan extension effects of caffeine and related methylxanthines in Caenorhabditis elegans

  2019cites this paper
• Motor Functioning and Parkinson’s Disease: Insights from the general population

  2019cites this paper
• Epidemiology of Parkinson's Disease—East Versus West

  2018cites this paper
• Biomarkers for detection, prognosis and therapeutic assessment of neurological disorders

  2018cites this paper
• Interaction between caffeine and polymorphisms of glutamate ionotropic receptor NMDA type subunit 2A (GRIN2A) and cytochrome P450 1A2 (CYP1A2) on Parkinson's disease risk

  2018cites this paper
• Distinct progression pattern of susceptibility MRI in the substantia nigra of Parkinson's patients

  2018cites this paper
• Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area

  2018cites this paper
• Association of Coffee Drinking With Mortality by Genetic Variation in Caffeine Metabolism: Findings From the UK Biobank

  2018cites this paper
• The role of exposure to pesticides in the etiology of Parkinson’s disease: a 18F-DOPA positron emission tomography study

  2018cites this paper
• The Impact of Coffee and Caffeine on Multiple Sclerosis Compared to Other Neurodegenerative Diseases

  2018cites this paper
• The Search for Environmental Causes of Parkinson’s Disease: Moving Forward

  2018cites this paper
• Use of Herbal Products/Alternative Medicines in Neurodegenerative Diseases (Alzheimer’s Disease and Parkinson’s Disease)

  2018cites this paper
• Caffeine in teas: levels, transference to infusion and estimated intake

  2018cites this paper
• Health benefits of methylxanthines in neurodegenerative diseases.

  2017cites this paper
• Développement d'un modèle murin de la maladie de Parkinson par augmentation compensatoire de l'arborisation axonale dopaminergique-nigrostriée

  2017cites this paper
• Relationship between smoking and olfactory dysfunction in Parkinson's disease

  2017cites this paper
• Long-term exposure to air pollution and the incidence of Parkinson’s disease: A nested case-control study

  2017cites this paper
• Coffee, Caffeine, and Health Outcomes: An Umbrella Review.

  2017cites this paper
• The Changing Landscape of Parkinson Epidemiologic Research

  2017cites this paper
• Decreased circulating Zinc levels in Parkinson’s disease: a meta-analysis study

  2017cites this paper
• Differences in Parkinson’s Disease Risk with Caffeine Intake and Postmenopausal Hormone Use

  2017cites this paper
• The neuroprotective effects of caffeine in neurodegenerative diseases

  2017cites this paper